Fundamentals

Valuation

Metric	Q2	Q3	Δ in %
EV/EBITDA	-83.38	-3.66	22.03
Graham Fair Price	inf	0.00	7.96
PEG	inf	0.00	0.02
Price/Book	inf	0.00	0.92
Price/Cash Flow	inf	0.00	-34.81
Prices/Earnings	inf	0.00	-4.99
Price/Sales	inf	0.00	10.08
Price/FCF	inf	0.00	-34.81
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q2	Q3	Δ in %
Gross Profit Margin	57.20	1.00	0.64
Operating Margin	-49.92	0.21	0.43
ROA	30.57	< 0.005	< 0.005
ROE	-0.05	-0.01	77.15
ROIC	0.03	-0.19	490.14
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q2	Q3	Δ in %
Debt QOQ	0.00	-1.00	inf
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	-0.66	-4.82	-626.79
EPS QOQ	-2.57	1.00	-61.02
FCF QOQ	0.49	0.00	inf
Revenue QOQ	-0.81	-8.63	-963.92
Naive Interpretation	member

03 - Financial Growth · Weak

Fundamentals

Leverage & Liquidity

Metric	Q2	Q3	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	6399.91	0.00	inf
Days Sales Outstanding (DSO)	3981.50	0.00	inf
Inventory Turnover	0.01	0.00	inf
Debt/Capitalization	0.00	0.32	100.00
Quick Ratio	0.42	< 0.005	-98.69
Naive Interpretation	member

04 - Leverage & Liquidity · Bad

Fundamentals

Per Share Metrics

Metric	Q2	Q3	Δ in %
Book Value	7.82	0.00	inf
Cash	0.35	0.00	inf
Capex	0.00	0.00	0.00
Free Cash Flow	-0.21	0.00	inf
Revenue	0.71	0.00	inf
Naive Interpretation	member

05 - Per Share Metrics · Not Interpreted

Fundamentals

Financial Health

Metric	Q2	Q3	Δ in %
Current Ratio	1.40	1.86	33.21
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	-0.53	-3.66	-590.19
Naive Interpretation	Member

06 - Financial Health · Weak

Rating